Page last updated: 2024-08-21

aminoimidazole carboxamide and Fatty Liver, Nonalcoholic

aminoimidazole carboxamide has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, X; Lin, M; Men, J; Wang, Q; Yuan, Y; Zhang, M	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Fatty Liver, Nonalcoholic

Article	Year
The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα. Bioscience reports, 2018, 12-21, Volume: 38, Issue:6 Topics: Acetyl-CoA Carboxylase; Alanine Transaminase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Bupleurum; Cholesterol, HDL; Cholesterol, LDL; Drugs, Chinese Herbal; Gene Expression Regulation; Hep G2 Cells; Humans; Medicine, Chinese Traditional; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Ribonucleosides; Sterol Regulatory Element Binding Protein 2; Triglycerides	2018

Article

Year

The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.

Bioscience reports, 2018, 12-21, Volume: 38, Issue:6

Topics: Acetyl-CoA Carboxylase; Alanine Transaminase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Bupleurum; Cholesterol, HDL; Cholesterol, LDL; Drugs, Chinese Herbal; Gene Expression Regulation; Hep G2 Cells; Humans; Medicine, Chinese Traditional; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Ribonucleosides; Sterol Regulatory Element Binding Protein 2; Triglycerides

2018